In the clinical trial conducted by Rezk-Allah et al.28, a reduction in serum TNF-alpha levels was observed in breast cancer patients treated with PBMT, aligning with previous findings from in-vitro and in-vivo experimental studies34–36. Here, TNF is linked to breast cancer.